Germany· DE-A57-27e22506f199165d
Paidoflor
A lactobacillus acidophilus product containing lactobacillus acidophilus, registered in Germany by Ardeypharm Gmbh. The same ATC class is registered in 2 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Lactobacillus acidophilus is registered in 2 of 19 countries.
Countries holding a registration under ATC J07AX04 (lactobacillus acidophilus), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 1 of them publish a price we can compare per daily dose
Lactobacillus acidophilus · ATC J07AX04
2 / 19 countries
- Germany
- Spainprice
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Lactobacillus Acidophilus
- Manufacturer
- Ardeypharm Gmbh
- Country
- Germany (DE)
- ATC code
- J07AX04
- ATC class
- Lactobacillus acidophilus
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
282 interactions on record for lactobacillus acidophilus.
Graded by severity as the source publishes them — 282 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Lactobacillus acidophilus · interactions on record
282 records
- 282 moderate
Most severe, free to view
- VancomycinA07AA09moderate
- RifaximinA07AA11moderate
- FidaxomicinA07AA12moderate
- PrednisoloneA07EA01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Lactobacillus acidophilus in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Spain · Casenfilus
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d0f69837-7237-466b-9471-12c87d408471 GET /v1/drugs/d0f69837-7237-466b-9471-12c87d408471?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Lactobacillus Acidophilus",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about lactobacillus acidophilus.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.